Wockhardt Ltd

NSE: WOCKPHARMA · BSE: 532300 · Pharmaceuticals & Biotechnology · 35 announcements

Share price: ₹2,034.60
Market cap: ₹33,065 Cr
Revenue (annual): ₹3,373 Cr
Net profit (annual): ₹213.0 Cr
P/E (TTM): 80.7×Sector 43.8×
Promoter holding: 49.32%+0.24% QoQ
FII holding: 7.02%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 6 Board Meeting Date 6 Financial Results 4 Annual General Meeting 4 Management Change 3 Results Update 2 Legal & Regulatory 2 Earnings Call 2 Business Update 2 Regulatory Approval 1 Fund Raise 1 Employee Stock Options 1 Credit Rating 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

2 Nov 2026 16:59 IST NSE

Results Update

Wockhardt Results Update

Wockhardt reported Q2 FY27 PAT of Rs.73 Cr on revenue of Rs.969 Cr, up 24%. Biotech operations grew 68%, driven by emerging markets.

Open announcement → Read the filing ↗

4 May 2026 15:44 IST NSE

Results Update

Wockhardt Limited reported a positive Profit Before Tax (PBT) of ₹238 Crore for FY26 on total revenue of ₹3,373 Crore. Q4FY26 revenue grew 30% to ₹965 Crore, driven by biotech and antibiotic segments. The company successfully completed Phase 3 trials for five novel antibiotics and holds 859 patents.

Value: ₹3,373 Cr

Open announcement → Read the filing ↗